IMV Inc IMVIF

RE:meeting with management

[europe10]

Thanks bikkel78
1. Ovarian is a montherapy - but results have not been staggering.
2. Bladder cancer can be super interesting! Problems -- money....so the "talks with various companies" must click
3. Short term, it is ALL about DLBCL. "Mega strong" should create interest, still finncing needed!
Unless Merck suddenly makes a deal. Likely too early/not enough patients. Hope I am wrong.
4. Platform ----- yes long term this is the huge potential. As time has passed - now a small likelyhood
5. This - is a very positive remark! We have all noted the lack of insider buying so let's hope this is the reason

Friday "last chance" for IMV?